相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteostasis and neurodegeneration: The roles of proteasomal degradation and autophagy
Keiji Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models
Xiu-Qi Bao et al.
BRAIN RESEARCH (2014)
Effects of Physical Exercise on the P38MAPK/REDD1/14-3-3 Pathways in the Myocardium of Diet-Induced Obesity Rats
B. L. S. Pieri et al.
HORMONE AND METABOLIC RESEARCH (2014)
RTP801 Regulates Maneb- and Mancozeb-Induced Cytotoxicity via NF-κB
Shu-Yuan Cheng et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2014)
Plasma membrane translocation of REDD1 governed by GPCRs contributes to mTORC1 activation
Gregory Michel et al.
JOURNAL OF CELL SCIENCE (2014)
REDD1 is essential for stress-induced synaptic loss and depressive behavior
Kristie T. Ota et al.
NATURE MEDICINE (2014)
Emerging therapies for Parkinson's disease: From bench to bedside
F. I. Tarazi et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-A mechanistic approach
Maria Teresa Baltazar et al.
TOXICOLOGY LETTERS (2014)
Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease
J. Romani-Aumedes et al.
CELL DEATH & DISEASE (2014)
RTP801 Gene Expression Is Differentially Upregulated in Retinopathy and Is Silenced by PF-04523655, a 19-Mer siRNA Directed Against RTP801
Kay D. Rittenhouse et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride
Susana del Olmo-Aguado et al.
BRAIN RESEARCH BULLETIN (2013)
ATF4 Protects Against Neuronal Death in Cellular Parkinson's Disease Models by Maintaining Levels of Parkin
Xiaotian Sun et al.
JOURNAL OF NEUROSCIENCE (2013)
mTORC1 Dependent Regulation of REDD1 Protein Stability
Chia Yee Tan et al.
PLOS ONE (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients
Q. D. Nguyen et al.
EYE (2012)
Retina Expression and Cross-Species Validation of Gene Silencing by PF-655, a Small Interfering RNA Against RTP801 for the Treatment of Ocular Disease
Dong U. Lee et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells
Yuning Zhou et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
FLZ PROTECTS DOPAMINERGIC NEURON THROUGH ACTIVATING PROTEIN KINASE B/MAMMALIAN TARGET OF RAPAMYCIN PATHWAY AND INHIBITING RTP801 EXPRESSION IN PARKINSON'S DISEASE MODELS
X. -Q. Bao et al.
NEUROSCIENCE (2012)
Micro-RNA30c Negatively Regulates REDD1 Expression in Human Hematopoietic and Osteoblast Cells after Gamma-Irradiation
Xiang Hong Li et al.
PLOS ONE (2012)
Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)
Quan Dong Nguyen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801
Xiao-mei Wu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Akt as a Victim, Villain and Potential Hero in Parkinson's Disease Pathophysiology and Treatment
Lloyd A. Greene et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
A novel cardioprotective p38-MAPK/mTOR pathway
Gonzalo Hernandez et al.
EXPERIMENTAL CELL RESEARCH (2011)
RTP801/REDD1 Regulates the Timing of Cortical Neurogenesis and Neuron Migration
Cristina Malagelada et al.
JOURNAL OF NEUROSCIENCE (2011)
miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1
W. W. Hwang-Verslues et al.
ONCOGENE (2011)
The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases
Jason R. Cannon et al.
TOXICOLOGICAL SCIENCES (2011)
Downregulation of Akt/mammalian target of rapamycin pathway in skeletal muscle is associated with increased REDD1 expression in response to chronic hypoxia
Francois B. Favier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Structural Analysis and Functional Implications of the Negative mTORCl Regulator REDD1
Silvia Vega-Rubin-de-Celis et al.
BIOCHEMISTRY (2010)
Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1
Robin M. Hobbs et al.
CELL (2010)
Rapamycin Protects against Neuron Death in In Vitro and In Vivo Models of Parkinson's Disease
Cristina Malagelada et al.
JOURNAL OF NEUROSCIENCE (2010)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
miR-221 overexpression contributes to liver tumorigenesis
Pascal Pineau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
Peter Horak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
Oren A. Levy et al.
APOPTOSIS (2009)
ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression
Michael L. Whitney et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase
Samiksha Katiyar et al.
EMBO REPORTS (2009)
Activating transcription factor 4 and CCAAT/enhancer-binding protein-β negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress
Hyeon-Ok Jin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients
Milena Damjanac et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Lucia Migliore et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Luke S. Tain et al.
NATURE NEUROSCIENCE (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling
Maurice Phillip DeYoung et al.
GENES & DEVELOPMENT (2008)
RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
Cristina Malagelada et al.
JOURNAL OF NEUROSCIENCE (2008)
Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis
Scot R. Kimball et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1α and Sp1 through the phosphatidylinositol 3-kinase/Akt signaling pathway
Hyeon-Ok Jin et al.
CELLULAR SIGNALLING (2007)
The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells
Dan Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells
Dan Zhang et al.
NEUROPHARMACOLOGY (2007)
RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation
Cristina Malagelada et al.
JOURNAL OF NEUROSCIENCE (2006)
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
SL Cai et al.
JOURNAL OF CELL BIOLOGY (2006)
Arsenite induces a cell stress-response gene, RTP801, through reactive oxygen species and transcription factors Elk-1 and CCAAT/enhancer-binding protein
L Lin et al.
BIOCHEMICAL JOURNAL (2005)
Regulation of mTOR and cell growth in response to energy stress by REDD1
A Sofer et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway
MN Corradetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of a cell stress response gene RTP801 by DNA damaging agent methyl methanesulfonate through CCAAT/enhancer binding protein
L Lin et al.
BIOCHEMISTRY (2005)
Analysis of gene expression changes in a cellular model of Parkinson disease
EJ Ryu et al.
NEUROBIOLOGY OF DISEASE (2005)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
The hypoxia-induced paralogs scylla and charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila
JH Reiling et al.
GENES & DEVELOPMENT (2004)
Inhibition of oxygen-induced retinopathy in RTP801-deficient mice
A Brafman et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1
M Cammalleri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of amyloid β-peptide responsive genes by cDNA microarray technology:: Involvement of RTP801 in amyloid P-peptide toxicity
JR Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2003)
Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb
AR Tee et al.
CURRENT BIOLOGY (2003)
New perspectives in arsenic-induced cell signal transduction
Y Qian et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
K Inoki et al.
GENES & DEVELOPMENT (2003)
Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals
ZQ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Altered proteasomal function in sporadic Parkinson's disease
KS McNaught et al.
EXPERIMENTAL NEUROLOGY (2003)
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species
LW Ellisen et al.
MOLECULAR CELL (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis
T Shoshani et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus
SJ Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
NR Jana et al.
HUMAN MOLECULAR GENETICS (2001)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
